Hanmi exports combo drug to overseas markets

Local drug maker Hanmi Pharm said on July 20 that it will export its independently developed incrementally modified drug (IMD) to overseas markets through a multinational pharmaceutical company.

The company said on July 21 that Amosartan, which combines amlodipine camsylate with losartan, will be exported to six Asian countries, including Indonesia, Malyasia, the Philippines and Singapore fr...